Risk factors associated with recurrence of tuberculosis at the Chest Clinic, Hospital Raja Perempuan Zainab II Kota Bharu Malaysia
| Format: | Restricted Document |
|---|
| _version_ | 1860797356957499392 |
|---|---|
| building | INTELEK Repository |
| collection | Online Access |
| collectionurl | https://intelek.unisza.edu.my/intelek/pages/search.php?search=!collection407072 |
| date | 2015-10-25 10:40:50 |
| format | Restricted Document |
| id | 12393 |
| institution | UniSZA |
| internalnotes | 1. World Health Organization. 2010/2011 Tuberculosis Global Facts. Available from http://www.who.int/tb/publications/2010/factsheet_tb_2010.pdf 2. Yew WW, Leung CC. Are Some People Not Safer after Successful Treatment of Tuberculosis? Am J Respir Crit Care Med 2005; 171(12): 1324-1325. 3. Panjabi R, Comstock GW, Golub JE. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis 2007; 11(8): 828-837. 4. Anyama N, Sseguya S, Okwera A, El-Naggar WE, Mpagi F, Owino E. The challenge of re-treatment pulmonary tuberculosis at two teaching and referral hospitals in Uganda. Afr Health Sci 2007; 7(3): 136-142. 5. World Health Organization. Tuberculosis. 2014. Available from http://www.who.int/mediacentre/factsheets/fs104/en/ 6. World Health Organization. Global tuberculosis control 2010. Available from http://www.sante.public.lu/publications/maladies-traitements/tuberculose/global-tuberculosis-control/global-tuberculosis-control-2010.pdf 7. Ministry of Health. Clinical Practice Gudielines. Management of Tuberculosis. 3rd Edition. Malaysia Health Technology Assessment Section (MaHTAS), Medical Development Division, Ministry of Health Malaysia, Level 4, Block E1, Precinct 1, Federal Government Administrative Centre 62590, Putrajaya, Malaysia. 2012. Available from http://www.moh.gov.my/attachments/8612.pdf (Accessed 30/12/2014) 8. Ministry of Health. Health Facts 2009. Available from http://vlib.moh.gov.my/cms/documentstorage/com.tms.cms.document.Document_4add873f-c0a81049-13ce5ad0-9b5bdb32/2009.pdf (Accessed 30/12/2014) 9. Dobler CC, Crawford ABH, Jelfs PJ, Gilbert GL, Marks GB. Recurrence of tuberculosis in a low-incidence setting. Eur Respir J 2009; 33(1): 160-167. 10. TBCTA. TB cap (2005-2010). http://www.tbcta.org/Content/2/Tuberculosis Accessed 20 April 2010. 2011. 11. Yamagishi F, Toyota M. Research and control of relapse tuberculosis cases. Kekkaku 2009; 84(12): 767-8. 12. Cacho J, Meixeira AP, Cano I, Soria T, Ramos Martos A, Sánchez Concheiro M, et al. Recurrent tuberculosis from 1992 to 2004 in a metropolitan area. Eur Respir J 2007; 30(2):333-7. 13. Selassie AW, Pozsik C, Wilson D, Ferguson PL. Why pulmonary tuberculosis recurs: a population-based epidemiological study. Ann Epidemiol 2005; 15(7): 519-25. 14. Selassie AW, Wilson DA. #92 Quantification of the risk of recurrence in tuberculosis. Annals of Epidemiology 2002; 12(7): 524. 15. Rehm J, Samokhvalov AV, Neuman MG, Room R, Parry C, Lönnroth K. et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health 2009; 9: 450. 16. Lönnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C. Alcohol Use as a Risk Factor for Tuberculosis -- A Systematic Review. BMC Public Health 2008; 8: 289. 17. Thomas A, Gopi PG, Santha T, Chandrasekaran V, Subramani R, Selvakumar N. et al. Predictors of relapse among pulmonary TB in patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis 2005; 9(5): 556-561. 18. Sahly HME, Wright JA, Soini H, Bui TT, Williams-Bouyer N, Escalante P. et al. Recurrent TB in Houston, Texas: a population-based study. Int J Tuberc Lung Dis 2004; 8(3): 333-340. 19. World Health Organization. Malaysia TB country profile. 2013. Available https://extranet.who.int/sree/Reports?op=Replet&name=/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=my&outtype=pdf 20. Jee SH, Golub JE, Jo J, Park IS, Ohrr H, Samet JM. Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol 2009; 170(12): 1478-85. 21. Verver S, Warren RM, Beyers N, Richardson M, van der Spuy GD, Borgdorff MW et al. Rate of Reinfection Tuberculosis after Successful Treatment Is Higher than Rate of New Tuberculosis. Am J Respir Crit Care Med 2005; 171(12): 1430-1435. 22. Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey-Faussett P et al. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 2001; 358(9294): 1687-1693. 23. Driver CR, Munsiff SS, Li J, Kundamal N, Osahan SS. Relapse in persons treated for Drug-Susceptible TB in a population with High Coinfection with HIV in New York City. Clin Infect Dis 2001; 33(10): 1762-1769. 24. Malbrán DCG. Manual for the Bacteriological Diagnosis of Tuberculosis. Available from http://www1.paho.org/english/ad/dpc/cd/tb-labs-baciloscopia.htm 25. Kang'ombe CT, Harries AD, Ito K, Clark T, Nyirenda TE, Aldis W, et al. Long-term outcome in patients registered with tuberculosis in Zomba, Malawi: mortality at 7 years according to initial HIV status and type of TB. Int J Tuberc Lung Dis 2004; 8(7): 829-836. 26. Frieden T. What is intermittent treatment and what is the scientific basis for intermittency?" and Toman’s tuberculosis: case detection, treatment, and monitoring—questions and answers, 2nd Edition. World Health Organization, Geneva, Switzerland; 2004. Available from http://www.tbrieder.org/publications/books_english/toman_2.pdf 27. Chang K C, Leung CC, Yew WW, Chan SL, Tam CM. Dosing Schedules of 6-Month Regimens and Relapse for Pulmonary Tuberculosis. Am J Respir Crit Care Med 2006; 174(10): 1153-8. 28. Datiko D G, Lindtjørn B. Tuberculosis recurrence in smear-positive patients cured under DOTS in southern Ethiopia: retrospective cohort study. BMC Public Health 2009; 9:348. 29. Batista Jd’AL, de Albuquerque MFPM, Ximenes RA de A, Rodrigues LC. Smoking increases the risk of relapse after successful tuberculosis treatment. Int J Epidemiol 2008; 37(4): 841-851. 30. Shen G, Xue Z, Shen X, Sun B, Gui X, Shen M, et al. Recurrent tuberculosis and exogenous reinfection, Shanghai, China. Emerg Infect Dis 2006; 12(11): 1776-1778. 31. Ottmani SE, Murray MB, Jeon CY, Baker MA, Kapur A, Lönnroth K, et al. Consultation meeting on TB and DM: meeting summary and recommendations. Int J Tuberc Lung Dis 2010; 14(12): 1513-1517. 32. Millet JP, Orcau A, de Olalla PG, Casals M, Rius C, Caylà JA, et al. Tuberculosis recurrence and its associated risk factors among successfully treated patients. J Epidemiol Community Health 2009, 63(10):799-804. 33. Khan FA, Minion J, Pai M, Royce S, Burman W, Harries AD, et al. Treatment of active TB in HIV coinfected patients: A systematic review and meta-analysis. Clin Infect Dis 2010; 50(9): 1288-1299. 34. Swaminathan S, Narendran G, Venkatesan P, Iliayas S, Santhanakrishnan R, Menon PA, et al. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial. Am J Respir Crit Care Med 2010; 181(7): 743-751. 35. Fitzgerald DW, Desvarieux M, Severe P, Joseph P, Johnson WD Jr, Pape JW. Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. Lancet 2000; 356(9240): 1470-1474. 36. Charalambous S, Grant AD, Moloi V, Warren R, Day JH, van Helden P, et al. Contribution of reinfection to recurrent tuberculosis in South African gold miners. Int J Tuberc Lung Dis 2008; 12(8): 942-948. 37. Chaisson RE, Churchyard GJ. Recurrent Tuberculosis: Relapse, Reinfection, and HIV. J Infect Dis 2010; 201(5): 653-655. 38. Golub JE, Durovni B, King BS, Cavalacante SC, Pacheco AG, Moulton LH, et al. Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 2008; 22(18): 2527-2533. |
| originalfilename | 6695-01-FH02-FP-15-03928.jpg |
| person | UniSZA Unisza unisza |
| recordtype | oai_dc |
| resourceurl | https://intelek.unisza.edu.my/intelek/pages/view.php?ref=12393 |
| spelling | 12393 https://intelek.unisza.edu.my/intelek/pages/view.php?ref=12393 https://intelek.unisza.edu.my/intelek/pages/search.php?search=!collection407072 Restricted Document Article Journal UniSZA Unisza unisza image/jpeg inches 96 96 1421 71 71 748 2015-10-25 10:40:50 1421x748 6695-01-FH02-FP-15-03928.jpg UniSZA Private Access Risk factors associated with recurrence of tuberculosis at the Chest Clinic, Hospital Raja Perempuan Zainab II Kota Bharu Malaysia International Journal of Pharmaceutical Research Introduction: Tuberculosis (TB) was the disease with the second highest incidence rate and caused the highest mortality rate among communicable diseases in Malaysia. Current study wants to identify the associated factors of recurrence among TB patients. Methods: A retrospective record review study of 114 patients registered as recurrent TB cases attending the Chest Clinic of Hospital Raja Perempuan Zainab II (HRPZ II), Kelantan, Malaysia within January 2003 to December 2009 were conducted. The Cox Proportional Hazards Regression analysis was used. Results: After adjustment of other potential confounding variables, the alcoholism (adjusted Hazard ratio [aHR]: 24.53, 95% CI:1.96,306.29), the sputum smear result at the initial diagnosis of previous occurrence of TB (aHR: 4.09, 95% CI:1.52,11.02) were more likely to have recurrent TB whereas the treatment regimen with twice weekly doses of Streptomycin (S), Isoniazid (H) and Rifampicin (R) drugs (S2H2R2) during the continuation phase (aHR: 0.11,95% CI:0.02,0.54)was found as a significant protective factor for recurrent TB. Conclusion: The recurrent TB cases can be reduced by treating the patients with S2H2R2 drug regimen during the continuation phase while we must be aware of hazards of recurrent TB for alcoholics and patients with positive sputum smear result at the initial diagnosis of TB. 7 2 76-82 1. World Health Organization. 2010/2011 Tuberculosis Global Facts. Available from http://www.who.int/tb/publications/2010/factsheet_tb_2010.pdf 2. Yew WW, Leung CC. Are Some People Not Safer after Successful Treatment of Tuberculosis? Am J Respir Crit Care Med 2005; 171(12): 1324-1325. 3. Panjabi R, Comstock GW, Golub JE. Recurrent tuberculosis and its risk factors: adequately treated patients are still at high risk. Int J Tuberc Lung Dis 2007; 11(8): 828-837. 4. Anyama N, Sseguya S, Okwera A, El-Naggar WE, Mpagi F, Owino E. The challenge of re-treatment pulmonary tuberculosis at two teaching and referral hospitals in Uganda. Afr Health Sci 2007; 7(3): 136-142. 5. World Health Organization. Tuberculosis. 2014. Available from http://www.who.int/mediacentre/factsheets/fs104/en/ 6. World Health Organization. Global tuberculosis control 2010. Available from http://www.sante.public.lu/publications/maladies-traitements/tuberculose/global-tuberculosis-control/global-tuberculosis-control-2010.pdf 7. Ministry of Health. Clinical Practice Gudielines. Management of Tuberculosis. 3rd Edition. Malaysia Health Technology Assessment Section (MaHTAS), Medical Development Division, Ministry of Health Malaysia, Level 4, Block E1, Precinct 1, Federal Government Administrative Centre 62590, Putrajaya, Malaysia. 2012. Available from http://www.moh.gov.my/attachments/8612.pdf (Accessed 30/12/2014) 8. Ministry of Health. Health Facts 2009. Available from http://vlib.moh.gov.my/cms/documentstorage/com.tms.cms.document.Document_4add873f-c0a81049-13ce5ad0-9b5bdb32/2009.pdf (Accessed 30/12/2014) 9. Dobler CC, Crawford ABH, Jelfs PJ, Gilbert GL, Marks GB. Recurrence of tuberculosis in a low-incidence setting. Eur Respir J 2009; 33(1): 160-167. 10. TBCTA. TB cap (2005-2010). http://www.tbcta.org/Content/2/Tuberculosis Accessed 20 April 2010. 2011. 11. Yamagishi F, Toyota M. Research and control of relapse tuberculosis cases. Kekkaku 2009; 84(12): 767-8. 12. Cacho J, Meixeira AP, Cano I, Soria T, Ramos Martos A, Sánchez Concheiro M, et al. Recurrent tuberculosis from 1992 to 2004 in a metropolitan area. Eur Respir J 2007; 30(2):333-7. 13. Selassie AW, Pozsik C, Wilson D, Ferguson PL. Why pulmonary tuberculosis recurs: a population-based epidemiological study. Ann Epidemiol 2005; 15(7): 519-25. 14. Selassie AW, Wilson DA. #92 Quantification of the risk of recurrence in tuberculosis. Annals of Epidemiology 2002; 12(7): 524. 15. Rehm J, Samokhvalov AV, Neuman MG, Room R, Parry C, Lönnroth K. et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health 2009; 9: 450. 16. Lönnroth K, Williams BG, Stadlin S, Jaramillo E, Dye C. Alcohol Use as a Risk Factor for Tuberculosis -- A Systematic Review. BMC Public Health 2008; 8: 289. 17. Thomas A, Gopi PG, Santha T, Chandrasekaran V, Subramani R, Selvakumar N. et al. Predictors of relapse among pulmonary TB in patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis 2005; 9(5): 556-561. 18. Sahly HME, Wright JA, Soini H, Bui TT, Williams-Bouyer N, Escalante P. et al. Recurrent TB in Houston, Texas: a population-based study. Int J Tuberc Lung Dis 2004; 8(3): 333-340. 19. World Health Organization. Malaysia TB country profile. 2013. Available https://extranet.who.int/sree/Reports?op=Replet&name=/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=my&outtype=pdf 20. Jee SH, Golub JE, Jo J, Park IS, Ohrr H, Samet JM. Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol 2009; 170(12): 1478-85. 21. Verver S, Warren RM, Beyers N, Richardson M, van der Spuy GD, Borgdorff MW et al. Rate of Reinfection Tuberculosis after Successful Treatment Is Higher than Rate of New Tuberculosis. Am J Respir Crit Care Med 2005; 171(12): 1430-1435. 22. Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey-Faussett P et al. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 2001; 358(9294): 1687-1693. 23. Driver CR, Munsiff SS, Li J, Kundamal N, Osahan SS. Relapse in persons treated for Drug-Susceptible TB in a population with High Coinfection with HIV in New York City. Clin Infect Dis 2001; 33(10): 1762-1769. 24. Malbrán DCG. Manual for the Bacteriological Diagnosis of Tuberculosis. Available from http://www1.paho.org/english/ad/dpc/cd/tb-labs-baciloscopia.htm 25. Kang'ombe CT, Harries AD, Ito K, Clark T, Nyirenda TE, Aldis W, et al. Long-term outcome in patients registered with tuberculosis in Zomba, Malawi: mortality at 7 years according to initial HIV status and type of TB. Int J Tuberc Lung Dis 2004; 8(7): 829-836. 26. Frieden T. What is intermittent treatment and what is the scientific basis for intermittency?" and Toman’s tuberculosis: case detection, treatment, and monitoring—questions and answers, 2nd Edition. World Health Organization, Geneva, Switzerland; 2004. Available from http://www.tbrieder.org/publications/books_english/toman_2.pdf 27. Chang K C, Leung CC, Yew WW, Chan SL, Tam CM. Dosing Schedules of 6-Month Regimens and Relapse for Pulmonary Tuberculosis. Am J Respir Crit Care Med 2006; 174(10): 1153-8. 28. Datiko D G, Lindtjørn B. Tuberculosis recurrence in smear-positive patients cured under DOTS in southern Ethiopia: retrospective cohort study. BMC Public Health 2009; 9:348. 29. Batista Jd’AL, de Albuquerque MFPM, Ximenes RA de A, Rodrigues LC. Smoking increases the risk of relapse after successful tuberculosis treatment. Int J Epidemiol 2008; 37(4): 841-851. 30. Shen G, Xue Z, Shen X, Sun B, Gui X, Shen M, et al. Recurrent tuberculosis and exogenous reinfection, Shanghai, China. Emerg Infect Dis 2006; 12(11): 1776-1778. 31. Ottmani SE, Murray MB, Jeon CY, Baker MA, Kapur A, Lönnroth K, et al. Consultation meeting on TB and DM: meeting summary and recommendations. Int J Tuberc Lung Dis 2010; 14(12): 1513-1517. 32. Millet JP, Orcau A, de Olalla PG, Casals M, Rius C, Caylà JA, et al. Tuberculosis recurrence and its associated risk factors among successfully treated patients. J Epidemiol Community Health 2009, 63(10):799-804. 33. Khan FA, Minion J, Pai M, Royce S, Burman W, Harries AD, et al. Treatment of active TB in HIV coinfected patients: A systematic review and meta-analysis. Clin Infect Dis 2010; 50(9): 1288-1299. 34. Swaminathan S, Narendran G, Venkatesan P, Iliayas S, Santhanakrishnan R, Menon PA, et al. Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial. Am J Respir Crit Care Med 2010; 181(7): 743-751. 35. Fitzgerald DW, Desvarieux M, Severe P, Joseph P, Johnson WD Jr, Pape JW. Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial. Lancet 2000; 356(9240): 1470-1474. 36. Charalambous S, Grant AD, Moloi V, Warren R, Day JH, van Helden P, et al. Contribution of reinfection to recurrent tuberculosis in South African gold miners. Int J Tuberc Lung Dis 2008; 12(8): 942-948. 37. Chaisson RE, Churchyard GJ. Recurrent Tuberculosis: Relapse, Reinfection, and HIV. J Infect Dis 2010; 201(5): 653-655. 38. Golub JE, Durovni B, King BS, Cavalacante SC, Pacheco AG, Moulton LH, et al. Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil. AIDS 2008; 22(18): 2527-2533. |
| spellingShingle | Risk factors associated with recurrence of tuberculosis at the Chest Clinic, Hospital Raja Perempuan Zainab II Kota Bharu Malaysia |
| summary | Introduction: Tuberculosis (TB) was the disease with the second highest incidence rate and caused the highest mortality rate among communicable diseases in Malaysia. Current study wants to identify the associated factors of recurrence among TB patients. Methods: A retrospective record review study of 114 patients registered as recurrent TB cases attending the Chest Clinic of Hospital Raja Perempuan Zainab II (HRPZ II), Kelantan, Malaysia within January 2003 to December 2009 were conducted. The Cox Proportional Hazards Regression analysis was used. Results: After adjustment of other potential confounding variables, the alcoholism (adjusted Hazard ratio [aHR]: 24.53, 95% CI:1.96,306.29), the sputum smear result at the initial diagnosis of previous occurrence of TB (aHR: 4.09, 95% CI:1.52,11.02) were more likely to have recurrent TB whereas the treatment regimen with twice weekly doses of Streptomycin (S), Isoniazid (H) and Rifampicin (R) drugs (S2H2R2) during the continuation phase (aHR: 0.11,95% CI:0.02,0.54)was found as a significant protective factor for recurrent TB. Conclusion: The recurrent TB cases can be reduced by treating the patients with S2H2R2 drug regimen during the continuation phase while we must be aware of hazards of recurrent TB for alcoholics and patients with positive sputum smear result at the initial diagnosis of TB. |
| title | Risk factors associated with recurrence of tuberculosis at the Chest Clinic, Hospital Raja Perempuan Zainab II Kota Bharu Malaysia |
| title_full | Risk factors associated with recurrence of tuberculosis at the Chest Clinic, Hospital Raja Perempuan Zainab II Kota Bharu Malaysia |
| title_fullStr | Risk factors associated with recurrence of tuberculosis at the Chest Clinic, Hospital Raja Perempuan Zainab II Kota Bharu Malaysia |
| title_full_unstemmed | Risk factors associated with recurrence of tuberculosis at the Chest Clinic, Hospital Raja Perempuan Zainab II Kota Bharu Malaysia |
| title_short | Risk factors associated with recurrence of tuberculosis at the Chest Clinic, Hospital Raja Perempuan Zainab II Kota Bharu Malaysia |
| title_sort | risk factors associated with recurrence of tuberculosis at the chest clinic, hospital raja perempuan zainab ii kota bharu malaysia |